Supplements · General functional

Nattokinase

ナットウキナーゼ (Nattō kināze)

Also known as: Natto enzyme, Bacillus subtilis natto protease

2Japanese suppliers ready to quoteView on the Sourcing platform

At a glance

CategorySupplements
Common Japanese notationsナットウキナーゼ, 納豆キナーゼ
CAS number133876-92-3
OriginFermented (Bacillus subtilis var. natto)
Typical functionsSmooth blood flow (FFC endpoint)
Regulatory status in JapanFFC-accepted for smooth blood flow endpoints. Industry body JNKA sets purity and activity standards.

Nattokinase is a fibrinolytic serine protease (EC 3.4.21.62) identified in 1980 by Dr. Hiroyuki Sumi from the sticky coating of natto. Japanese manufacturers — led by JBSL since 1998 — have developed high-activity concentrates (measured in Fibrinolytic Units, FU) that are now widely used in cardiovascular-positioned supplements globally.

Find OEM manufacturers

Browse Japanese OEM manufacturers that build products in this category. Filter by small lot, certifications, prefecture.

Classification

Tags below link to other ingredients sharing the same attribute, so you can pivot from one ingredient to its peers.

Common OEM product categories

Finished-product categories where Japanese OEM manufacturers commonly formulate with this ingredient.

  • Cardiovascular-positioned supplements
  • Functional capsules

Ingredient profile

A 275-amino-acid serine protease produced exclusively by Bacillus subtilis var. natto during soybean fermentation. Molecular weight approximately 27,700 Da. Activity is measured in FU (Fibrinolytic Units) using the fibrin-plate method.

Imitation products sold in several overseas markets use different enzymes (subtilisin NAT, Korean chungkookjang kinase, fungal proteases). Buyers should verify B. subtilis natto origin and the presence of the JNKA mark. Vitamin K2-reduced grades are available for formulations requiring compatibility with anticoagulant medications.

OEM applications

Cardiovascular-positioned supplements (capsules, tablets) — the primary application.

Functional foods with FFC notifications on smooth blood flow.

Regulatory classification in Japan

Accepted as a Foods with Function Claims (FFC) ingredient for smooth blood flow endpoints; JNKA mark requires 2,000+ FU per daily dose.

Confirm vitamin K2 removal if targeting users on warfarin-type medications; clinical precaution required regardless of supplement status.

Regulatory classification in other markets

USADietary supplement under DSHEA. Safety/labeling disclosures apply.
EUFood supplement category; novel food evaluation may apply for specific extract preparations. Verify with current EFSA guidance.
China / Korea / TaiwanRegistered supplement ingredient; verify local labeling norms.

Market reference formulations

Example finished products and brands will be added after ingredient-list verification. Avoid citing medical-disease claims; restrict descriptions to FFC-accepted wording.

All brand names and product names referenced anywhere on this site are the property of their respective owners. Example entries are provided for informational purposes only and do not imply endorsement.

Typical OEM use levels

Formulation ranges per finished-product application. Verify against the cited source before production.

ApplicationTypical rangeRegulatory limitNotes
Functional Food (FFC) — blood circulation / fluidity claim (Japan)Daily intake 2,000 FU (fibrinolytic units) per FFC notifications (representative)Per consumer-affairs notification; published in 機能性表示食品DB消費者庁 機能性表示食品データベース

Storage requirements

How the receiving OEM facility needs to handle inbound raw material.

Temperature
Refrigerated 4°C for activity retention; freezer for stock
Conditions
Sealed against moisture; activity (FU) declines under heat / humidity
Shelf life
24 months sealed cold; activity loss accelerates above 25°C

Industry stability data + 日本ナットウキナーゼ協会

Supply concentration

Where this ingredient comes from — useful for single-source-risk planning.

Primary regions
Ibaraki, Tochigi (natto industry centers); Daiwa Pharmaceutical and JBSL major producers
Import dependence
Premium grade is domestic; commodity supply also from Korea / China

日本ナットウキナーゼ協会

Certifications commonly available

Certification schemes commonly obtainable for this raw material. Always confirm the specific supplier's current certificate before contracting.

SchemeAvailability
GMP (food / supplement)StandardRequired for FFC notification
HalalOn-requestBacillus-fermentation source can be Halal-cert; specific suppliers (e.g., JBSL) carry cert
KosherOn-request
VeganCommonBacillus-derived; non-animal
Non-GMOOn-requestSoy substrate sourcing matters
FFC notification readyStandardMost suppliers provide 機能性表示食品 dossier-ready material

Alternative ingredients

Related ingredients commonly evaluated as substitutes.

Quick answers

What is Nattokinase?
Nattokinase is a fibrinolytic serine protease (EC 3.4.21.62) identified in 1980 by Dr. Hiroyuki Sumi from the sticky coating of natto. Japanese manufacturers — led by JBSL since 1998 — have developed high-activity concentrates (measured in Fibrinolytic Units, FU) that are now widely used in cardiovascular-positioned supplements globally.
What is the regulatory status of Nattokinase in Japan?
FFC-accepted for smooth blood flow endpoints. Industry body JNKA sets purity and activity standards.
What products typically use Nattokinase?
Cardiovascular-positioned supplements / Functional capsules
Where does Nattokinase come from?
Fermented (Bacillus subtilis var. natto)

FAQ for OEM buyers

Q. What is nattokinase?

Nattokinase is a fibrinolytic serine protease (EC 3.4.21.62) of approximately 27.7 kDa, identified by Dr. Hiroyuki Sumi in 1980 from the sticky coating of natto (Japanese fermented soybeans).

Q. How is nattokinase activity measured?

Activity is conventionally measured in Fibrinolytic Units (FU) using the fibrin-plate method. The Japan NattoKinase Association (JNKA) sets purity and activity standards used in the Japanese market.

Q. Is all nattokinase the same?

No — only enzymes produced by Bacillus subtilis var. natto qualify as authentic nattokinase. Some imitation products use other enzymes such as subtilisin or fungal proteases. Buyers should verify the production strain and look for the JNKA mark.

Q. What is the FFC endpoint commonly notified for nattokinase in Japan?

Common FFC notifications cite a smooth blood flow endpoint. Specific brand-claim wording must follow each individual notification on file with the Consumer Affairs Agency.

Use cases

  • Cardiovascular-positioned supplements (capsules)

    Positioning
    Smooth blood flow under FFC where notified
    Typical usage level
    ≥2,000 FU per daily dose for JNKA-certified products
    Formulation notes
    Enteric coating common; protect from heat and humidity
  • FFC functional foods

    Positioning
    Smooth blood flow positioning
    Formulation notes
    Endpoint wording must mirror individual FFC notification
  • Export supplements (US/EU/Asia)

    Positioning
    Cardiovascular wellness — non-disease, non-drug claims only
    Formulation notes
    Verify EU novel-food status of the specific extract; localize labeling

Search the academic literature

Pre-filled queries for the major research databases. Opens in a new tab.

Official regulatory databases

External links to public Japanese / international regulatory authorities. We are not affiliated.

References

  1. Japan Nattokinase Association (JNKA) standards
  2. FFC database — Consumer Affairs Agency

Last updated: 2026-04-23. Ingredient entries are reviewed at least annually against current regulatory listings.

Explore more Japan-market resources

Related tools for overseas buyers, formulators, and sourcing teams.